Integrated Wealth Management (Palm Desert)’s Alnylam Pharmaceuticals ALNY Stock Holding History

Integrated Wealth Management (Palm Desert)’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-500	Closed	-$34K	–	264
2016 Q3	$34K	Hold	500	–	–	0.01%	489
2016 Q2	$28K	Hold	500	–	–	0.01%	521
2016 Q1	$31K	Hold	500	–	–	0.01%	457
2015 Q4	$47K	Sell	500 -318	-39%	-$29.5K	0.02%	400
2015 Q3	$66K	Hold	818	–	–	0.03%	330
2015 Q2	$98K	Hold	818	–	–	0.04%	281
2015 Q1	$85K	Buy	+818	New	+$82.9K	0.04%	296

Other funds holding ALNY

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

SPC

Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Integrated Wealth Management (Palm Desert)'s ALNY Position: Q4 2016 in Review

Integrated Wealth Management (Palm Desert) sold out of Alnylam Pharmaceuticals (ALNY) in Q4 2016, closing a stake of 500 shares — an estimated $34K sold.

Integrated Wealth Management (Palm Desert) first reported a position in ALNY in Q1 2015 and held it in 7 quarters. The position peaked at $98K in Q2 2015. 211 funds tracked by Wall St. Rank hold ALNY as of Q4 2016.

Integrated Wealth Management (Palm Desert) reported no remaining Alnylam Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Integrated Wealth Management (Palm Desert) sold 500 Alnylam Pharmaceuticals shares in Q4 2016, an estimated $34K.
Integrated Wealth Management (Palm Desert) first reported a position in Alnylam Pharmaceuticals in Q1 2015 and held it in 7 quarters.
Integrated Wealth Management (Palm Desert)'s Alnylam Pharmaceuticals position peaked at $98K in Q2 2015.
211 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q4 2016.

Based on Integrated Wealth Management (Palm Desert)'s 13F filing for Q4 2016, filed 6 Jan 2017.